Search results

• 2010

  Lck is a key target of imatinib and dasatinib in T-cell activation

  Lee, K. C., Ouwehand, I., Giannini, A. L., Thomas, N. S., Dibb, N. J. & Bijlmakers, M. J., Apr 2010, In: Leukemia. 24, 4, p. 896 - 900 5 p.

  Research output: Contribution to journal › Letter › peer-review
  73 Citations (Scopus)